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Abstract 
Introduction: We have studied optical imaging of mice cerebrospinal fluid (CSF) space and flow using near 
infrared fluorescence.  We applied our method to image CSF space and flow in a mice hydrocephalus model. 
Material and Methods: Hydrocephalus was induced in mice with intracranial injections of transforming growth 
factor.  Hydrocephalic and control mice were imaged using our near infrared fluorescence imaging system.  
Results: Hydrocephalic mice showed diminished intracranial CSF flow. Discussion: Our system is sufficient to 
show altered CSF flow in a mouse hydrocephalus model.  Optical imaging using near infrared is an effective 
modality to image CSF space and movement. 
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Introduction 
Clinically, dynamic cerebrospinal fluid (CSF) imaging is performed using 
radioisotope (RI) or computed tomography (CT) cisternography or cine-mode 
magnetic resonance imaging (cine MRI).  RI cisternography has low spatial 
resolution and involves the complicated handling of radioisotopic materials. CT 
cisternography shows axial tomographic images with high spatial resolution, 
however sagittal images are not possible. In addition, there is the possibility of 
adverse reactions induced by intrathecally injected metrizamide [1]. Both RI and 
CT cisternography have the disadvantage of involving exposure to ionizing 
radiation. Cine MRI is non-invasive and has high resolution, however the entire 
flow dynamics, including wash out from the CSF space, is not evaluated [2]. 
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To overcome these limitations, we have developed an optical method of 
CSF space imaging and flow measurement using a novel near infrared (NIR) 
fluorescence imaging methodology.  Previously we reported imaging of CSF 
space and movement using this method in normal mice [3].  The objective of 
this study is to employ this method to evaluate pathological CSF flow in 
hydrocephalic mice.  
Hydrocephalus is a typical pathological CSF flow disease.  In our study, 
communicating hydrocephalus in mice was induced by an intrathecal injection 
of human recombinant transforming growth factor β1 (TGF-β1).  TGF-β1 
injected mice are expected to exhibit ventricular dilatation within 3 weeks [4] 
and in this study they undergo imaging studies 4 weeks after the injection.   
Material and Methods 
Compounds 
Indocyanine green (ICG) is a tricarbocyanine dye which, as an aqueous 
solution, has a major absorption peak at approximately 780 nm, a minor peak at 
approximately 700 nm, and fluorescent emission peak at approximately 820 nm. 
ICG (Sigma-Aldrich, St. Louis, MO) was prepared as 6.45mM solution in 0.8% 
NaCl.  Human high-density lipoprotein (HDL, Sigma-Aldrich, St. Louis, MO) 
was prepared as 10mg/ml solution in phosphate buffered saline (PBS, Sigma-
Aldrich, St. Louis, MO).  Five micro liter of prepared 6.45mM ICG solution was 
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mixed with 0.5 ml of prepared 10 mg/ml human HDL solution because ICG is 
bound to lipoprotein in circulating blood [5].  Human TGF-β1 was purchased 
from Sigma-Aldrich (St. Louis, MO).  100 mg of Bovine serum albumin (BSA) 
powder (Sigma-Aldrich, St. Louis, MO) was dissolved in 100 ml of PBS.  One 
microgram of TGF-β1 was dissolved in 1ml of PBS with 0.1% BSA.    
Induction of hydrocephalus 
CD-1 Nude mice were purchased from Charles River Laboratories 
(Wilmington, MA).  Communicating hydrocephalus was induced in mice using 
the method of Tada et al. [3].  Mice were anesthetized with intraperitoneal 
injection of a mixture of ketamine (100mg/kg) and xylazine (10mg/kg) at day 10 
and day 11 after birth.  Then, on each day, 300 ng of TGF-β1 in 30 μl of PBS 
was injected into the parietal lobe using a Hamilton microsyringe (Hamilton, 
Reno, Nevada).  Control mice were injected with 30 μl of PBS with 0.1% BSA 
on each day.  
After the mice reached 6 weeks old, they were anesthetized by 
intraperitoneal injection of ketamine and xylazine.  The body weight of each 
mouse was measured just before the injection of anesthesia.  Under a 
stereoscopic operating microscope, the 5th lumbar lamina was removed and the 
spinal cord covered with dura matter was exposed. Then, 5 μl of ICG-HDL 
mixture was injected into the spinal subarachnoid space using a Hamilton 
microsyringe.   
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Imaging hardware 
Anesthetized mice were positioned in the optical imaging system 
developed in our laboratory.  Prior to each measurement, the head and feet were 
carefully located at the same positions on the stage of imaging system. The 
system was configured for epi-fluorescence measurements at NIR wavelengths 
using the illumination light from a 450 W Xe arc lamp (Oriel Instruments, 
Stratford, CT) and narrow band excitation filtration obtained by an interference 
filter (Omega Optical, Andover, MA, custom order) with a bandwidth of 33 nm 
and central wavelength of 755 nm.  Emission light was filtered with a long pass 
optical filter (Omega Optical) with a cutoff at 798 nm.  Whole-body images 
were digitized by a high resolution, cooled, CCD digital camera (ORCA-ER, 
Hamamatsu, Hamamatsu City, Japan) attached to a Pentium III-based personal 
computer running Lab VIEW 6 system integration and automation software 
(National Instruments, Austin, TX).   
Image acquisition and processing 
The progress of ICG tracer was monitored by the imaging system as 
evidenced by the intensity of the NIR fluorescence signal emitted. Dynamic 
measurements of CSF movement were obtained by repeating the imaging 
procedure at 0.5, 1, 2, 4, 6, 24 hours post injection. In addition, some mice were 
imaged at 30 and 48 hours following injection of the tracer. Quantitative 
assessment of CSF movement was assessed by placing regions of interest on 
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emission images and plotting the time-intensity profiles. If we could detect a 
clear signal from the basal cistern, we placed ROIs at these points. If the basal 
cistern signal was not detectable, we put ROIs at appropriate positions using the 
head and ear locations as references. 
All images were acquired with the lens aperture set to F/1.6 and in the full 
resolution (1280 X 1024 pixels), non-binning, frame blanking acquisition mode 
of the Hamamatsu camera. The exposure time for all images was 1.2 seconds. 
Each image was acquired using Lab VIEW 6 software in PNG format. 
These images were processed and converted to TIFF format using custom 
software running on MATLAB release 12.1. (The Mathworks Inc., Natick MA).  
Further image manipulation, compression to 8-bit scale and annotations were 
performed with Photoshop 6.0 software (Adobe systems Inc., San Jose, CA) on 
a Pentium III-based personal computer under the Windows 2000 PC platform. 
The CSF movement was investigated in hydrocephalus and control mice.  
A total of 11 TGF-β1 injected hydrocephalic mice and 10 PBS injected control 
mice were imaged.  The CSF movement patterns were established and the time-
intensity curves were analyzed.   
Ventricle/brain ratio 
 After the image acquisition, every mouse was sacrificed and the brain was 
removed.  After fixation using 10% formaldehyde solution, the brain was 
sectioned in the coronal plane and the ventricle/brain ratio was measured as the 
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maximum width of ventricle to maximum width of brain.  In order to compare 
the effect of the intrathecal injections, normal mice without any intrathecal 
injection were used in this study.  Body weight and ventricle/brain ratio were 
measured in the same manner for some normal mice.  This animal experiment 
protocol was approved by the Harvard medical area standing committee on 
animals and the Beth Israel Deaconess Medical Center Institutional Animal Care 
& Use Committee.  
Results 
Body weight of mice 
 Mean body weight of 12 TGF-β1 injected mice was 22.9+4.72 g.  Mean 
body weight of 16 PBS injected control mice was 20.98+3.17 g.  Mean body 
weight of 23 normal 6-week-old nude mice was 24.27+2.44 g.  TGF-β1 injected 
mice showed significantly lighter body weight than normal mice (Student’s t-
test, p<0.05) and there was no significant difference between TGF-β1 injected 
mice and PBS injected mice. 
 The evaluation of the toxicity of the intrathecal injection of ICG-HDL is 
beyond the scope of this paper. Although we did not experience any acute 
complications caused by the intrathecal injection of ICG-HDL, a study of the 
toxicity of intrathecal injection of ICG-HDL should be performed prior to the 
application of this method in humans. 
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Ventricle/brain ratio 
 The fixed brains were sectioned and ventricle/brain ratios were measured. 
Coronal sectioning was not done appropriately for one mouse in each of the 
TGF-β1 and PBS injected mouse groups and so these data were omitted from 
the analysis. Mean ventricle/brain ratio of 11 TGF-β1 injected mice was 
0.66+0.11.  Mean ventricle/brain ratio of 15 PBS injected control mice was 
0.54+0.04.  Mean ventricle/brain ratio of 7 normal 6-week-old nude mice was 
0.53+0.08.  The ventricle/brain ratios of the TGF-β1 injected mice were 
significantly higher than those of PBS injected (Student’s t-test, p<0.01) and 
normal mice (Student’s t-test, p<0.05).  There was no difference between the 
mean ventricle/brain ratios of control and normal mice. 
Serial imaging findings 
 Figure 1 shows typical images at 4 hours after the injection of ICG-HDL 
in both control and hydrocephalic mice.  The images of control mice show clear 
ICG accumulation at the cisterna magna and bilateral cerebello-pontine (C-P) 
angles.  Images of hydrocephalus mice demonstrate very limited signal. 
 As described in a previous paper, we placed regions of interest (ROI) at 
the cisterna magna and bilateral C-P angle cistern.  Full images were not 
obtained for 5 PBS injected mice, because of anesthetic loss.  Figure 2 shows the 
signal intensity changes within ROIs in the 10 PBS injected mice.  The signals 
from all ROIs exhibited peaks at 4 hours after the injection and decreased 
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thereafter.  Figure 3 showed mean signal intensity changes from ROIs in 11 
TGF-β1 injected mice.  The signals from all ROIs showed peaks at 4 hours after 
the injection.  All signals decreased thereafter, however the signal from cisterna 
magna exhibited delayed washout compared to control mice.  The TGF-β1 
injected mice exhibit lower signal intensity at bilateral C-P angles comparing 
with control mice, although this is not statistically significant (Student’s t-test).  
Discussion 
Image findings from hydrocephalic mice 
 Our results indicated that intrathecal injection of TGF-β1 or PBS causes 
growth retardation and only TGF-β1 injection induced ventricular enlargement.  
TGF-β1 injected hydrocephalic mice showed diminished CSF movement 
compared to control mice and our method of imaging CSF flow using NIR 
fluorescence was sufficient to observe and analyze CSF movement of mice. 
Moinuddin reported a significant lengthening of the ink passage time and ink 
stasis in the altered leptomeningeal space in TGF-β1 injected mice [6].  These 
findings are in agreement with our own.  We found no other reports of imaging 
TGF-β1 injected mice in the literature.  In humans, early and persistent 
ventricular reflux is a typical finding of patients with communicating 
hydrocephalus [1,7].  In our experiments with mice, no ventricular reflux was 
observed.  Moinuddin also did not report ventricular reflux and stasis [6].  In the 
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mouse, ventricles are located a few mm below the cerebral surface, so the 
ventricle is within the range of our imaging technique.  We believe that because 
of remarkable diminution of the CSF flow in hydrocephalic mice, significant 
amounts of dye didn’t enter the ventricles even though there was ventricular 
reflux.  The CSF dynamics might be different between mice and humans. The 
presence of ventricular reflux in TGF-β1 injected mice might be examined using 
different dosing or administration methods of TGF-β1. 
Mouse hydrocephalus model 
 There are several methods to induce hydrocephalus in mice.  Historically 
hydrocephalus has been induced by intrathecal injection of silicone oil, kaolin 
and laminalia [8].  These methods induce severe inflammation at the 
subarachnoid cistern and cause obstructive hydrocephalus.  Milder forms of 
hydrocephalus have been induced using transgenic mice and fetal exposure to 
irradiation, drugs or infection [9].  These methods are costly, not efficient and 
not safe for mice.   
There are several rodent models with inherited hydrocephalus.  
Aqueductal stenosis is a common observation in congenital hydrocephalus and 
prenatal hydrocephalus has a poor prognosis [10].  The H-Tx rat is a 
homozygous carrier of an autosomal recessive hydrocephalus gene with 
incomplete penetrance [10,11].  Most hydrocephalic H-Tx rats die between 4 
and 5 weeks of age. Transgenic mice that overexpress TGF-β1 in the central 
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nervous systems have been reported [12,13].  These mice develop severe 
hydrocephalus and die between birth and 3 weeks of age [13].    
Communicating hydrocephalus is typical mild hydrocephalus in adult 
human patients after cerebrovascular disease.   The malabsorption of CSF is the 
cause of communicating hydrocephalus and there is no obstruction of CSF flow. 
As a rodent model of adult human communicating hydrocephalus, the mouse 
should survive for a prolonged period without severe disability.  In our study, 
communicating hydrocephalus in mice was induced by intrathecal injection of 
human recombinant TGF-β1.  Tada et al. established this method and reported 
that it was easy, safe and effective [4].  In their experience, all TGF-β1 injected 
mice showed ventricular dilatation within 3 weeks and survived more than 6 
weeks after the injection.  This method involves intracerebral injection of TGF-
β1, so some brain damage is inevitable. We experienced early death of newborn 
mice immediately after intracranial injection of TGF-β1.  Pathological 
examination of these 2 dead mice showed intracerebral hemorrhage.  A technical 
refinement of the intracranial injection method such as the use of stereotactic 
apparatus might prevent some complications. In our experiment, some mice did 
not survive 4 weeks post injection, however, all TGF-β1 injected mice that 
survived for 4 weeks showed ventricular dilatation.  The degree of ventricular 
dilatation was quite variable as Tada has reported.   
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TGF-β1 
 TGF-β1 is a dimmer of a 25-kDa polypeptide. TGF-β has been isolated as 
the protein to induce a transformed phenotype in rat fibroblasts [14].  In the 
developing central nervous system, the presence of TGF-β1 and expression of 
TGF-β1 receptors occur preferentially in meninges and the subarachnoid space 
in both hydrocephalic and normal mice [15].  Activated T lymphocytes secrete 
greatly elevated levels of TGF-β, so TGF-β is one of the lymphokines produced 
by T lymphocytes [16].  TGF-β1 is chemotactic to monocytes and fibroblasts 
and enhances angiogenesis and formation of extracellular matrix proteins such 
as collagen and fibronectin [17].  In addition, TGF-β1 is known to cause 
formation of granulation tissue, fibrosis in wound healing, certain fibrotic 
diseases such as liver cirrhosis, pulmonary fibrosis and glomerulonephritis 
[16,18].  Kitazawa found elevated levels of TGF-β1 in the CSF of patients with 
hydrocephalus after subarachnoid hemorrhage [19]. TGF-β1 injected mice 
showed inter-meningeal fibrosis and a subsequent narrowing of the 
intrameningeal CSF space [6,20].  We believe that the consequence of 
intracranial injection of TGF-β1 is a good model of communicating 
hydrocephalus because it has the same pathophysiology as human 
hydrocephalus after subarachnoid hemorrhage.  Optimizing the dose, timing and 
delivery method might make this model more efficient and convenient.   
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 We can induce communicating hydrocephalus model in nude mice via 
intrathecal injection of TGF-β1. Nude mice do not have mature T lymphocytes 
[21].  These findings reveal therefore that the induction of hydrocephalus using 
TGF-β1 doesn’t require mature T lymphocytes. This means that subarachnoid 
fibrosis induced by TGF-β1 results from a direct proliferative response rather 
than indirect chemotactic actions or immune responses.  In addition, TGF-β1 is 
immunosuppressive in vivo and depresses the number and activity of natural 
killer cells [22,23].  Leukocytes from nude mice produced less active TGF-β1 
than those from normal mice [23].  These findings support the mechanism of 
subarachnoid fibrosis induced by TGF-β1, that is the direct formation of 
extracellular matrix proteins by fibroblasts.  
Advantage and limitation of optical imaging 
The advantages of optical imaging are noninvasiveness except for the 
injection of a fluorescent probe and rapid and repeatable image acquisition.  The 
imaging system is compact and portable, so that intraoperative and bedside 
applications could be possible.  The disadvantages are the reduction in image 
quality due to the photon scattering and the limitation of signal acquisition from 
deep tissue.  Our study clarified the usefulness of this technique for CSF flow 
imaging in nude mice.  The application of this methodology in human CSF flow 
imaging would be challenging without future technical innovations.     
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Legends of figures 
Fig. 1  Typical images at 4 hours after the injection of ICG-HDL in both hydrocephalus and control 
mice 
Fig. 2  Mean signal intensity over time from ROIs located over brain regions in 10 PBS injected 
control mice 
Fig. 3  Mean signal intensity over time from ROIs located over brain regions in 11 TGF−β1 injected 
hydrocephalus mice 
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Figure 1 
 
control mouse    hydrocephalic mouse 
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Figure 2 
Control mice(PBS it) (n=10)
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Figure 3 
Hydrocephalus mice (N=11)
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